Mycobacterium tuberculosis (Mtb) is the microorganism that causes tuberculosis. This
infectious disease has been around for centuries, with the earliest record of Mtb around …

Tuberculosis (TB) is still a worldwide public health burden, as more than 1.3 million deaths
are expected to be reported in 2021. Even though almost 20 million patients have completed …

Standard anti-tuberculosis treatment is highly effective, but a great challenge is the
management of adverse drug reactions (ADR). Our study aimed to characterize ADR …

Proceeding of Mulawarman Pharmaceuticals Conferences Page 1 15th Proc. Mul. Pharm.
Conf. 2021. e-ISSN: 2614-4778 Samarinda, 27-29 Mei 2022 231 Journal homepage: https://prosiding.farmasi.unmul.ac.id …

Background In tuberculosis (TB) treatment, adverse drug reactions (ADRs) can interrupt
treatment and decrease the quality of life (QoL). We aimed to prospectively investigate the …

Tuberculosis (TB) treatment failure is a health burden, as the patient remains a source of
infection and may lead to the development of multi-drug resistance (MDR). Information from …

Background: Despite the available treatment options, pulmonary tuberculosis (TB) remains a
leading cause of disease-related deaths worldwide. Treatment non-adherence/lost to follow …

Abstract Background Screening for Tuberculosis (TB) is a critical tactic for minimizing the
prevalence of illness within schools. Tuberculosis Preventive Therapy (TPT), in turn …

Background: India, with the highest number of tuberculosis (TB) cases in the world, is also
facing epidemic growth in diabetes mellitus (DM). TB is curable while DM is a metabolic and …

The pharmacovigilance has been evolved as a professional and ethical practice in ensuring
the safety of medicines. The Adverse Drug Reactions (ADRs) associated with the use of …